Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...

Asthma and chronic obstructive pulmonary disease (COPD ... stepwise approach to treatment, according to disease severity, including pulmonary rehabilitation, long-term oxygen therapy, surgery ...

Laboratory Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 ... Although this patient had preexisting chronic pulmonary disease, it was not severe enough to cause carbon ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...